Kyverna Therapeutics and ElevateBio, LLC announced a partnership to advance process development and manufacturing to produce industry-leading Ingenui-T-derived chimeric antigen receptor (CAR) T-cell therapies.
[Kyverna Therapeutics]
Home Newsletters Cell Therapy News Kyverna Therapeutics and ElevateBio to Advance Kyverna’s Ingenui-T Cell Therapy Manufacturing
